Rankings
▼
Calendar
PBYI Q3 2016 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
PBYI
Puma Biotechnology, Inc.
$305M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$66M
Net Income
-$66M
EPS (Diluted)
$-2.02
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$30M
Balance Sheet
Total Assets
$134M
Total Liabilities
$43M
Stockholders' Equity
$91M
Cash & Equivalents
$53M
← FY 2016
All Quarters
Q4 2016 →
